Brief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
BRIEF-Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model Sept 21 (Reuters) - Recursion Pharmaceuticals, Inc. RXRX.O:
TEMPUS AND RECURSION EXTEND EXISTING DATA LICENSE AGREEMENT AND ENTER NEW LICENSE AGREEMENT FOR RECURSION’S RNA FOUNDATION MODEL
TEMPUS AI, -CO AND RECURSION EXTEND DATA PARTNERSHIP THROUGH NOVEMBER 2029
TEMPUS AI, - RECURSION GRANTS TEMPUS NON-EXCLUSIVE WORLDWIDE LICENSE TO RNA SEQUENCING MODEL TXFM
Source text: ID:nBwr10Lya
Further company coverage: RXRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempus AI
See all newsU.S. STOCKS ON THE MOVE-Tempus AI, Choice Hotels, Palantir
Tempus AI rises after surprise quarterly profit
Tempus AI Q3 revenue slightly beats estimates; raises guidance
Brief: Tempus Receives Ivdr Certification For Xr Rna Sequencing For Solid Tumor Profiling
Brief: Tempus Expands Strategic Collaboration With Bristol Myers Squibb